IMPACT OF CANCER DIAGNOSIS ON SSI INCIDENCE
| Authors | |
|---|---|
| Year of publication | 2025 |
| Type | Conference abstract |
| MU Faculty or unit | |
| Citation | |
| Description | The aim of this study was to analyse the incidence of surgical site infections (SSIs) in patients undergoing surgery over a ten-year period and to compare it with that in patients diagnosed with cancer. Method: A retrospective analysis was performed using data from the Hospital Information System (HIS), focusing on patients who underwent surgery for a primary diagnosis of cancer. A total of 26,486 patients were included in the analysis, of whom 2,298 had an oncological diagnosis. Statistical significance was assessed at a level of 0.05 using t-tests, examining variables such as age, diagnosis, type of surgery, length of hospital stay and incidence of SSI. Results / Discussion: The results showed that the incidence of SSI was 2-3 times higher in cancer patients compared to non-cancer patients. The confidence intervals ranged from 2.83% to 6.36%, suggesting that there is a 95% probability that cancer patients have a significantly increased risk of developing an SSI. Age was not identified as a statistically significant factor for the occurrence of infections; however, SSIs led to longer hospital stays in both oncological and non-oncological patients. Conclusion: These findings confirm that oncological diagnosis is a significant factor influencing SSI incidence and highlight the need for targeted prevention and infection management strategies in this population. We recommend further research into specific factors that may increase the risk of SSI in cancer patients and interventions that may reduce these infections. The results of this study may contribute to improved patient care and reduced morbidity associated with surgical procedures in cancer patients. |